ANXA2 and neoplasm: It is reported that a cationic lipid-guided carrier with ANXA2 shRNA was designed to retarded tumor growth by silencing ANXA2, which have been proved a stable nanoparticle sustained targeting and localization in lung tumors nanoparticles both in vitro and in vivo127.